Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study.

Kostikas K, Vassilakopoulos TI, Tzanakis N, Konstantinidis AK, Kosmas EN, Papiris S, Steiropoulos P, Manali ED, Michaelides SA, Daskos G.

Int J Chron Obstruct Pulmon Dis. 2020 Mar 6;15:515-526. doi: 10.2147/COPD.S239044. eCollection 2020.

2.

First heterozygous NOP10 mutation in Familial Pulmonary Fibrosis.

Kannengiesser C, Manali ED, Revy P, Callebaut I, Ba I, Borgel A, Oudin C, Haritou A, Kolilekas L, Malagari K, Borie R, Lainey E, Boileau C, Crestani B, Papiris SA.

Eur Respir J. 2020 Mar 5. pii: 1902465. doi: 10.1183/13993003.02465-2019. [Epub ahead of print] No abstract available.

PMID:
32139460
3.

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.

Papiris SA, Griese M, Manali ED.

N Engl J Med. 2020 Jan 9;382(2):197. doi: 10.1056/NEJMc1914606. No abstract available.

PMID:
31914249
4.

Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease.

Wuyts WA, Wijsenbeek M, Bondue B, Bouros D, Bresser P, Robalo Cordeiro C, Hilberg O, Magnusson J, Manali ED, Morais A, Papiris S, Shaker S, Veltkamp M, Bendstrup E.

Respiration. 2020;99(1):73-82. doi: 10.1159/000504763. Epub 2019 Dec 12. Review.

5.

Emerging phenotypes of sarcoidosis based on 18F-FDG PET/CT: a hierarchical cluster analysis.

Papiris SA, Georgakopoulos A, Papaioannou AI, Pianou N, Kallergi M, Kelekis NL, Gialafos H, Manali ED, Chatziioannou S.

Expert Rev Respir Med. 2020 Feb;14(2):229-238. doi: 10.1080/17476348.2020.1684902. Epub 2019 Oct 29.

PMID:
31647341
6.

18F-FDG PET/CT in Pulmonary Sarcoidosis:Quantifying Inflammation by the TLG index.

Papiris SA, Manali ED, Pianou NK, Kallergi M, Papaioannou AI, Georgakopoulos A, Malagari K, Kelekis NL, Gialafos H, Chatziioannou S.

Expert Rev Respir Med. 2020 Jan;14(1):103-110. doi: 10.1080/17476348.2020.1682997. Epub 2019 Oct 24.

PMID:
31626563
7.

Mycophenolate mofetil as an alternative treatment in sarcoidosis.

Papiris S, Stagaki E, Papadaki G, Kolilekas L, Korbila I, Apollonatou V, Kallieri M, Gialafos H, Chatziioannou S, Papaioannou AI, Manali ED.

Pulm Pharmacol Ther. 2019 Oct;58:101840. doi: 10.1016/j.pupt.2019.101840. Epub 2019 Sep 10.

PMID:
31518648
8.

Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison.

Papiris SA, Tsirigotis P, Kannengiesser C, Kolilekas L, Gkirkas K, Papaioannou AI, Revy P, Giouleka P, Papadaki G, Kagouridis K, Pappa V, Borie R, Boileau C, Bouros D, Crestani B, Manali ED.

Respir Res. 2019 Aug 13;20(1):182. doi: 10.1186/s12931-019-1151-6.

9.

Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood.

Manali ED, Legendre M, Nathan N, Kannengiesser C, Coulomb-L'Hermine A, Tsiligiannis T, Tomos P, Griese M, Borie R, Clement A, Amselem S, Crestani B, Papiris SA.

ERJ Open Res. 2019 Jul 22;5(3). pii: 00066-2019. doi: 10.1183/23120541.00066-2019. eCollection 2019 Jul.

10.

Ability of using different dry powder inhalers during COPD exacerbations.

Papaioannou AI, Herodotou Y, Tomos I, Apollonatou V, Verykokou G, Papathanasiou E, Manali ED, Loukides S, Papiris SA.

Pulm Pharmacol Ther. 2018 Feb;48:211-216. doi: 10.1016/j.pupt.2017.12.007. Epub 2017 Dec 19.

PMID:
29277688
11.

High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.

Papiris SA, Tomos IP, Karakatsani A, Spathis A, Korbila I, Analitis A, Kolilekas L, Kagouridis K, Loukides S, Karakitsos P, Manali ED.

Cytokine. 2018 Feb;102:168-172. doi: 10.1016/j.cyto.2017.08.019. Epub 2017 Aug 25.

PMID:
28847533
12.

Massive hemoptysis in a patient with pulmonary embolism, a real therapeutic conundrum.

Herodotou Y, Papaioannou AI, Karakatsani A, Reppas L, Manali ED, Apollonatou V, Tomos I, Brountzos E, Papiris S.

Respir Med Case Rep. 2017 Feb 28;20:179-183. doi: 10.1016/j.rmcr.2017.02.013. eCollection 2017.

13.

Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers'.

Tomos IP, Tzouvelekis A, Aidinis V, Manali ED, Bouros E, Bouros D, Papiris SA.

Expert Rev Respir Med. 2017 Apr;11(4):299-309. doi: 10.1080/17476348.2017.1300533. Epub 2017 Mar 8. Review.

PMID:
28274188
14.

The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air.

Papiris SA, Kagouridis K, Kolilekas L, Karakatsani A, Korbila I, Giouleka P, Papadaki G, Maniati M, Bouros D, Manali ED.

Am J Respir Crit Care Med. 2017 Jan 15;195(2):267-269. doi: 10.1164/rccm.201607-1426LE. No abstract available.

PMID:
28084826
15.

Unilateral hypertransparency on chest radiograph: the congenital Poland Syndrome.

Tomos I, Papaioannou AI, Vlami A, Apollonatou V, Manali ED, Papiris SA.

Adv Respir Med. 2016;84(6):342-343. doi: 10.5603/ARM.2016.0045.

16.

Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.

Papaioannou AI, Kostikas K, Manali ED, Papadaki G, Roussou A, Kolilekas L, Borie R, Bouros D, Papiris SA.

Respir Med. 2016 Aug;117:14-26. doi: 10.1016/j.rmed.2016.05.005. Epub 2016 May 7. Review.

17.

Celebrating Two Centuries since the Invention of the Stethoscope. René Théophile Hyacinthe Laënnec (1781-1826).

Tomos I, Karakatsani A, Manali ED, Papiris SA.

Ann Am Thorac Soc. 2016 Oct;13(10):1667-1670.

PMID:
27467020
18.

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).

Papaioannou AI, Kostikas K, Manali ED, Papadaki G, Roussou A, Spathis A, Mazioti A, Tomos I, Papanikolaou I, Loukides S, Chainis K, Karakitsos P, Griese M, Papiris S.

PLoS One. 2016 Jun 23;11(6):e0157789. doi: 10.1371/journal.pone.0157789. eCollection 2016.

19.

Diffuse Idiopathic Skeletal Hyperostosis (DISH) and non small cell lung cancer: case presentation and review of the literature.

Tomos I, Vlami A, Karakatsani A, Korbila I, Manali ED, Papiris SA.

Pneumonol Alergol Pol. 2016;84(2):116-8. doi: 10.5603/PiAP.2016.0010. Review.

20.

Pharmacological management of IPF.

Borie R, Justet A, Beltramo G, Manali ED, Pradère P, Spagnolo P, Crestani B.

Respirology. 2016 May;21(4):615-25. doi: 10.1111/resp.12778. Epub 2016 Apr 12. Review.

21.

Acute Respiratory Events in Connective Tissue Disorders.

Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Maniati M, Filippatos G, Bouros D.

Respiration. 2016;91(3):181-201. doi: 10.1159/000444535. Epub 2016 Mar 4. Review.

22.

Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach.

Papiris SA, Kagouridis K, Kolilekas L, Papaioannou AI, Roussou A, Triantafillidou C, Baou K, Malagari K, Argentos S, Kotanidou A, Karakatsani A, Manali ED.

BMC Pulm Med. 2015 Dec 14;15:162. doi: 10.1186/s12890-015-0146-4.

23.

The Ring of the Aortas: The Silent Variation.

Tomos I, Vlami A, Korbila I, Manali ED, Karakatsani A, Papiris SA.

Ann Thorac Surg. 2015 Dec;100(6):2371. doi: 10.1016/j.athoracsur.2015.08.065. No abstract available.

PMID:
26652542
24.

Cardiovascular risk in pulmonary alveolar proteinosis.

Manali ED, Papadaki G, Konstantonis D, Tsangaris I, Papaioannou AI, Kolilekas L, Schams A, Kagouridis K, Karakatsani A, Orfanos S, Griese M, Papiris SA.

Expert Rev Respir Med. 2016 Feb;10(2):235-40. doi: 10.1586/17476348.2016.1116389. Epub 2015 Nov 27.

PMID:
26558331
25.

Surfactant Proteins in Smoking-Related Lung Disease.

Papaioannou AI, Papiris S, Papadaki G, Manali ED, Roussou A, Spathis A, Karakitsos P, Kostikas K.

Curr Top Med Chem. 2016;16(14):1574-81. Review.

PMID:
26420367
26.

"Luck's always to blame": silent wounds of a penetrating gunshot trauma sustained 20 years ago.

Tomos I, Manali ED, Argentos S, Raptakis T, Papiris SA.

Pneumonol Alergol Pol. 2015;83(5):392-3. doi: 10.5603/PiAP.2015.0063.

27.

Challenges in the classification of fibrotic ILD: Patient case 1.

Manali ED.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:10-2.

PMID:
26237437
28.

Challenges in the classification of fibrotic ILD.

Bendstrup E, Maher TM, Manali ED, Wijsenbeek M.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:4-9. Review.

PMID:
26237436
29.

Investigation of Lung Involvement in Connective Tissue Disorders.

Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Maniati M, Borie R, Pradere P, Crestani B, Bouros D.

Respiration. 2015;90(1):2-24. doi: 10.1159/000435817. Epub 2015 Jun 26. Review.

30.

Pulmonary alveolar proteinosis: time to shift?

Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, Papaporfyriou A, Karakatsani A, Kagouridis K, Griese M, Manali ED.

Expert Rev Respir Med. 2015 Jun;9(3):337-49. doi: 10.1586/17476348.2015.1035259. Epub 2015 Apr 12. Review.

PMID:
25864717
31.

Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.

Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, Papaporfyriou A, Karakatsani A, Kagouridis K, Griese M, Manali ED.

Clin Drug Investig. 2014 Aug;34(8):553-64. doi: 10.1007/s40261-014-0208-z.

PMID:
24890235
32.

Heart rate recovery post 6-minute walking test in obstructive sleep apnea: cycle ergometry versus 6-minute walking test in OSA patients.

Cholidou KG, Manali ED, Kapsimalis F, Kostakis ID, Vougas K, Simoes D, Markozannes E, Vogiatzis I, Bakakos P, Koulouris N, Alchanatis M.

Clin Res Cardiol. 2014 Oct;103(10):805-15. doi: 10.1007/s00392-014-0721-3. Epub 2014 May 13.

PMID:
24820928
33.

Idiopathic pulmonary fibrosis acute exacerbations: where are we now?

Papiris SA, Kagouridis K, Kolilekas L, Bouros D, Manali ED.

Expert Rev Respir Med. 2014 Jun;8(3):271-3. doi: 10.1586/17476348.2014.896206. Epub 2014 Mar 22.

PMID:
24655104
34.

Treating CTDs related fibrotic ILDs by immunosuppressants: "facts and faults".

Papiris SA, Kagouridis K, Papadaki G, Kolilekas L, Manali ED.

Lung. 2014 Apr;192(2):221-3. doi: 10.1007/s00408-013-9532-y. Epub 2013 Nov 12.

PMID:
24217988
35.

Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification.

Papiris SA, Malagari K, Manali ED, Kolilekas L, Triantafillidou C, Baou K, Rontogianni D, Bouros D, Kagouridis K.

Expert Rev Respir Med. 2013 Jun;7(3):289-306. doi: 10.1586/ers.13.21. Review.

PMID:
23734650
36.

Calprotectin: a protein related to cardiovascular risk in adult patients with obstructive sleep apnea.

Cholidou KG, Kostakis ID, Manali ED, Perrea D, Margeli A, Vougas K, Markozannes E, Koulouris N, Alchanatis M.

Cytokine. 2013 Mar;61(3):917-23. doi: 10.1016/j.cyto.2012.12.014. Epub 2013 Jan 29.

PMID:
23375123
37.

Combined pulmonary fibrosis and emphysema.

Papiris SA, Triantafillidou C, Manali ED, Kolilekas L, Baou K, Kagouridis K, Bouros D.

Expert Rev Respir Med. 2013 Feb;7(1):19-31; quiz 32. doi: 10.1586/ers.12.80. Review.

PMID:
23362797
38.

Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?

Papiris SA, Kagouridis K, Kolilekas L, Triantafillidou C, Tsangaris I, Manali ED.

Eur Respir J. 2012 Sep;40(3):794-5. doi: 10.1183/09031936.00114311. No abstract available.

39.

Steroids in idiopathic pulmonary fibrosis acute exacerbation: defenders or killers?

Papiris SA, Manali ED, Kolilekas L, Triantafillidou C, Tsangaris I, Kagouridis K.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):587-8. No abstract available.

PMID:
22383571
40.

Static and dynamic mechanics of the murine lung after intratracheal bleomycin.

Manali ED, Moschos C, Triantafillidou C, Kotanidou A, Psallidas I, Karabela SP, Roussos C, Papiris S, Armaganidis A, Stathopoulos GT, Maniatis NA.

BMC Pulm Med. 2011 May 31;11:33. doi: 10.1186/1471-2466-11-33.

41.

Medical Research Council dyspnea scale does not relate to fibroblast foci profusion in IPF.

Triantafillidou C, Manali ED, Magkou C, Sotiropoulou C, Kolilekas LF, Kagouridis K, Rontogianni D, Papiris SA.

Diagn Pathol. 2011 Apr 5;6:28. doi: 10.1186/1746-1596-6-28.

42.

Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread.

Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Triantafillidou C, Tsangaris I, Roussos C.

Crit Care. 2010;14(6):246. doi: 10.1186/cc9241. Epub 2010 Dec 22. Review.

43.

Amiodarone: review of pulmonary effects and toxicity.

Papiris SA, Triantafillidou C, Kolilekas L, Markoulaki D, Manali ED.

Drug Saf. 2010 Jul 1;33(7):539-58. doi: 10.2165/11532320-000000000-00000. Review.

PMID:
20553056
44.

MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.

Manali ED, Lyberopoulos P, Triantafillidou C, Kolilekas LF, Sotiropoulou C, Milic-Emili J, Roussos C, Papiris SA.

BMC Pulm Med. 2010 May 28;10:32. doi: 10.1186/1471-2466-10-32.

45.

High dose-rate endobronchial radiotherapy for proximal airway obstruction due to lung cancer: 8-year experience of a referral center.

Manali ED, Stathopoulos GT, Gildea TR, Fleming P, Thornton J, Xu M, Papiris SA, Mehta AC, Mughal MM.

Cancer Biother Radiopharm. 2010 Apr;25(2):207-13. doi: 10.1089/cbr.2009.0689.

PMID:
20423234
46.

Acute severe asthma: new approaches to assessment and treatment.

Papiris SA, Manali ED, Kolilekas L, Triantafillidou C, Tsangaris I.

Drugs. 2009;69(17):2363-91. doi: 10.2165/11319930-000000000-00000.

PMID:
19911854
47.

Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.

Tsimogianni AM, Papiris SA, Kanavaki S, Stathopoulos GT, Sotiropoulou C, Manali ED, Michalopoulou P, Roussos C, Kotanidou A.

Respirology. 2009 Nov;14(8):1114-20. doi: 10.1111/j.1440-1843.2009.01615.x. Epub 2009 Sep 16.

PMID:
19761538
48.

Predictors of outcome after exacerbation of chronic obstructive pulmonary disease.

Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou A.

J Gen Intern Med. 2009 Sep;24(9):1043-8. doi: 10.1007/s11606-009-1061-2. Epub 2009 Jul 14.

49.

Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer: association with response to treatment and survival.

Vlachogeorgos GS, Manali ED, Blana E, Legaki S, Karagiannidis N, Polychronopoulos VS, Roussos C.

Cancer. 2008 Dec 25;114(6):519-26. doi: 10.1002/cncr.23981.

50.

The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis.

Manali ED, Stathopoulos GT, Kollintza A, Kalomenidis I, Emili JM, Sotiropoulou C, Daniil Z, Roussos C, Papiris SA.

Respir Med. 2008 Apr;102(4):586-92. Epub 2007 Dec 26.

Supplemental Content

Loading ...
Support Center